title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,APLM,0.021778,Neutral,-0.092267
"Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket - Bed Bath & Beyond  ( NASDAQ:BBBY ) , Apollomics  ( NASDAQ:APLM ) ",20230426T123739,https://www.benzinga.com/news/23/04/32009221/why-bed-bath-beyond-shares-are-trading-lower-by-23-here-are-20-stocks-moving-premarket,APLM,0.188683,Neutral,-0.033848
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,APLM,0.020404,Neutral,-0.004464
